Literature DB >> 17525484

Molecular pathology of adrenal cortical tumors: separating adenomas from carcinomas.

Thomas J Giordano1.   

Abstract

Adrenal cortical carcinoma is a rare but interesting endocrine tumor. Its diagnosis is usually straightforward using morphologic assessment and supplemental immunohistochemistry. However, diagnostically challenging cases exist and pathologic evaluation would benefit from the availability of adjunctive molecular testing. Here, the relevant molecular pathology of adrenal cortical tumors is reviewed with special reference to those methods (e.g., DNA microarrays) that hold promise for improved diagnosis and prognosis, and prediction of therapeutic response.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17525484     DOI: 10.1007/s12022-006-0007-z

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   4.056


  59 in total

1.  Increased levels of insulin-like growth factor II (IGF-II) and IGF-binding protein-2 are associated with malignancy in sporadic adrenocortical tumors.

Authors:  N Boulle; A Logié; C Gicquel; L Perin; Y Le Bouc
Journal:  J Clin Endocrinol Metab       Date:  1998-05       Impact factor: 5.958

2.  Adrenocortical carcinoma is characterized by a high frequency of chromosomal gains and high-level amplifications.

Authors:  M Dohna; M Reincke; A Mincheva; B Allolio; S Solinas-Toldo; P Lichter
Journal:  Genes Chromosomes Cancer       Date:  2000-06       Impact factor: 5.006

Review 3.  Microarray and histopathological analysis of tumours: the future and the past?

Authors:  S R Lakhani; A Ashworth
Journal:  Nat Rev Cancer       Date:  2001-11       Impact factor: 60.716

4.  Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors.

Authors:  Frédérique Tissier; Catherine Cavard; Lionel Groussin; Karine Perlemoine; Gwladys Fumey; Anne-Marie Hagneré; Fernande René-Corail; Eric Jullian; Christine Gicquel; Xavier Bertagna; Marie-Cécile Vacher-Lavenu; Christine Perret; Jérôme Bertherat
Journal:  Cancer Res       Date:  2005-09-01       Impact factor: 12.701

5.  Detection of novel germ-line p53 mutations in diverse-cancer-prone families identified by selecting patients with childhood adrenocortical carcinoma.

Authors:  Y Sameshima; Y Tsunematsu; S Watanabe; T Tsukamoto; K Kawa-ha; Y Hirata; H Mizoguchi; T Sugimura; M Terada; J Yokota
Journal:  J Natl Cancer Inst       Date:  1992-05-06       Impact factor: 13.506

6.  p53 mutations in adrenal tumors: Caucasian patients do not show the exon 4 "hot spot" found in Taiwan.

Authors:  M Reincke; C Wachenfeld; P Mora; A Thumser; C Jaursch-Hancke; S Abdelhamid; G P Chrousos; B Allolio
Journal:  J Clin Endocrinol Metab       Date:  1996-10       Impact factor: 5.958

Review 7.  DNA-microarray analysis of brain cancer: molecular classification for therapy.

Authors:  Paul S Mischel; Timothy F Cloughesy; Stanley F Nelson
Journal:  Nat Rev Neurosci       Date:  2004-10       Impact factor: 34.870

8.  Genetic aberrations in adrenocortical tumors detected using comparative genomic hybridization correlate with tumor size and malignancy.

Authors:  M Kjellman; O P Kallioniemi; R Karhu; A Höög; L O Farnebo; G Auer; C Larsson; M Bäckdahl
Journal:  Cancer Res       Date:  1996-09-15       Impact factor: 12.701

Review 9.  Genetics of adrenocortical tumors: gatekeepers, landscapers and conductors in symphony.

Authors:  Constantine A Stratakis
Journal:  Trends Endocrinol Metab       Date:  2003-11       Impact factor: 12.015

10.  p53 mutations in sporadic adrenocortical tumors.

Authors:  H Ohgaki; P Kleihues; P U Heitz
Journal:  Int J Cancer       Date:  1993-05-28       Impact factor: 7.396

View more
  4 in total

1.  Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling.

Authors:  Thomas J Giordano; Rork Kuick; Tobias Else; Paul G Gauger; Michelle Vinco; Juliane Bauersfeld; Donita Sanders; Dafydd G Thomas; Gerard Doherty; Gary Hammer
Journal:  Clin Cancer Res       Date:  2009-01-15       Impact factor: 12.531

2.  Differential expression of microRNA-675, microRNA-139-3p and microRNA-335 in benign and malignant adrenocortical tumours.

Authors:  K J Schmitz; J Helwig; S Bertram; S Y Sheu; A C Suttorp; J Seggewiss; E Willscher; M K Walz; K Worm; K W Schmid
Journal:  J Clin Pathol       Date:  2011-04-06       Impact factor: 3.411

3.  Distinguishing adrenal cortical carcinomas and adenomas: a study of clinicopathological features and biomarkers.

Authors:  Cuiping Wang; Yang Sun; Huanwen Wu; Dachun Zhao; Jie Chen
Journal:  Histopathology       Date:  2013-11-23       Impact factor: 5.087

4.  Targeted RNAseq of Formalin-Fixed Paraffin-Embedded Tissue to Differentiate Among Benign and Malignant Adrenal Cortical Tumors.

Authors:  Samuel W Plaska; Chia-Jen Liu; Jung Soo Lim; Juilee Rege; Nolan R Bick; Antonio M Lerario; Gary D Hammer; Thomas J Giordano; Tobias Else; Scott A Tomlins; William E Rainey; Aaron M Udager
Journal:  Horm Metab Res       Date:  2020-08-13       Impact factor: 2.936

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.